CryoLife gets warning letter over manufacturing concerns

02/3/2013 | Reuters

The FDA has issued a warning letter to CryoLife saying that the company failed to sufficiently fix earlier issues regarding manufacturing practices tied to some of its products. CryoLife will cooperate with the FDA in addressing the concerns raised in the letter, according to the company, which develops surgical devices and instruments.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX